Tetrahydrocannabinol News and Research

RSS

Researchers harness the pain-relieving properties of cannabis to develop new pain killers

The cannabis plant produces pain-relieving molecules that are 30x more effective than aspirin. Researchers are now working on a plant-based pain killer.

25 Jul 2019

Marijuana isn’t a great choice for glaucoma treatment, says expert

Marijuana can help reduce the pressure inside the eye (IOP, or intraocular pressure). Being a euphoric drug, it is now a commonly used recreational and medicinal drug. In fact, its use ranks fourth among all substances, behind tobacco, alcohol and caffeine.

18 Jul 2019

Cannabis-based medication helps tackle dependency on cannabis

An Australian study has demonstrated that cannabis-based medication helps tackle dependency on cannabis, one of the most widely used drugs globally.

16 Jul 2019

Recreational marijuana users tend to drink more alcohol, medicinal users drink less

There is a lack of agreement about the relationship between marijuana and alcohol use. Does marijuana use increase or decrease alcohol consumption? Research based on interviews with users of both marijuana and alcohol reveals that recreational users tend to drink more alcohol, and medicinal users drink less alcohol, on marijuana-use days.

25 Jun 2019

Metabolic engineering of cannabinoids – are we there yet?

There has recently been a surge in research into the biosynthetic pathways of cannabinoids and the potential for commercialized metabolic engineering.

19 Jun 2019

Research on cannabis use in women limited, finds new study

A new study from the University of York shows that research into the association of psychosis with cannabis focuses almost completely on men users, significantly limiting our knowledge of the drug’s effects on human health.

5 Jun 2019

Synthetic CBD alternative effectively treats seizures in rats

A synthetic, non-intoxicating analogue of cannabidiol is effective in treating seizures in rats, according to research by chemists at the University of California, Davis.

28 May 2019

Long-term effects of cannabis on the adolescent brain

About one in five Canadian adolescents uses cannabis (19% of Canadians aged 15-19), and its recent legalization across the country warrants investigation into the consequence of this use on the developing brain. Adolescence

27 May 2019

Microextraction gets an eco-friendly makeover in new cannabis study

Researchers have successfully demonstrated that IT-SPME coupled to nano-LC is an adequate analytical method for the characterization of cannabis traces.

15 May 2019

The endocannabinoid system and skin conditions

a significant amount of research over the past 20 years has demonstrated that the endocannabinoid system plays a vital role in skin homeostasis, and therefore skin conditions too.

7 May 2019

Cannabis, Alcohol and the Epigenome

With the legalization of cannabis in many US states, we explore the epigenetic effects of cannabis, cannabis-derived products, and alcohol.

29 Apr 2019

Alcohol, Cannabis and Other Drugs: A Pharmacological Evaluation

Understanding the interactions between alcohol and cannabis can provide researchers, clinicians and other HCPs with important information on the severity of their side effects.

10 Apr 2019

Don't Believe the Hemp: UHPLC Analysis of Hemp Seed Oils

Despite the popularity of hemp seed oil products, there are currently no standardized analysis techniques. To this end, researchers have been exploring the use of HPLC-MS for cannabinoid profiling of hemp.

10 Apr 2019

Marijuana use during pregnancy may increase psychosis risk in offspring

Pregnant women who use cannabis may slightly increase the risk their unborn child will develop psychosis later in life, suggests new research from Washington University in St. Louis.

28 Mar 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

People with and without cancer use different dosages of cannabis formulations, study shows

People with and without cancer are more likely, over time, to use a more potent form of medical marijuana with increasingly higher amounts of tetrahydrocannabinol, a new study shows.

26 Mar 2019

Daily marijuana use may increase risk of psychosis

People who use marijuana on a daily basis may be at an increased risk of developing psychosis, particularly if it is high-potency, experts warn.

25 Mar 2019

High potency cannabis use linked to psychosis finds study

With more and more states and regions legalizing the use of medical marijuana or cannabis, experts are also looking at the long term effects of marijuana use and its safety. According to a new study published this week in the journal The Lancet Psychiatry, frequent use of marijuana can lead to psychotic episodes.

20 Mar 2019

Researchers solve major gap in scientific literature with mobile software technology

Researchers at the University of New Mexico recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day.

27 Feb 2019

Cannabis use as a teenager linked to depression later in life

A new study has shown that at least 400,000 cases of adults with depression in the US could have been avoided if greater measures were in place to discourage teenage use of cannabis. The results of this new study were published this week in the latest issue of the journal JAMA Psychiatry.

13 Feb 2019